Hua Medicine (2552 HK)

Hua Medicine is an innovative drug development and commercialization company focused on novel therapies for patients with unmet medical needs, particularly in diabetes care. Its cornerstone product is HuaTangNing (dorzagliatin tablets), a first-in-class oral drug for the treatment of Type 2 diabetes. The company was founded in 2011 and is headquartered in Shanghai, China.